跳至主要内容
临床试验/JPRN-UMIN000046535
JPRN-UMIN000046535尚未招募Unknown

A study to evaluate the effects of intake with food containing multiple ingredients on the reduction of including visceral fat-Randomized, double-blind, placebo-controlled parallel group study- - A study to evaluate the effects of intake with food containing multiple ingredients on the reduction of including visceral fat

ew drug research center, Inc.0 个研究点目标入组 81 人开始时间: 2023年3月1日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
81

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Subjects who fall under the diagnostic criteria of metabolic syndrome 2) Subjects who are under treatment of liver disease, kidney disease, heart disease, respiratory disease, endocrine disease, metabolic disease, neurological disease, consciousness disease, diabetes disease, other disorders 3) Subjects who are have a history of cardiovascular disease 4) Subjects who do not intakecarbohydrates (rice, bread, noodles) for all three meals a day 5) Subjects who use oral medication or supplements which may affect this study 6) Subjects who are sensitive to medical products, and other foods 7) Subjects who have experienced sickness due to blood collection 8) Subjects who donated 200 mL or more of blood within 1 month from the start of the study or subjects who plan to do so during the study period 9) Subjects who participated in other clinical studies in the past 1 months 10) Subjects who usually intake heavy amount of alcohol (40g alcohol/day>=) and who are excessive smoker(21 cigarettes/day>=) 11) Subjects who with irregular eating habits. (Night shift worker) 12) Subjects who wish to become pregnant during the study periods( including the possibility of pregnant) or who are lactation. 13) Subjects who can not agree with preliminary explanation 14) Subjects who gained or lost 5% or more of weight within 6 month from the study 15) Subjects who are ineligible due to physician's judgment

研究者

发起方
ew drug research center, Inc.

相似试验